NC Biomatrix Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$426K
- Investors
-
9
NC Biomatrix General Information
Description
Operator of a biotechnology company intended to focus on treating chronic back pain due to degenerative disc disease. The company offers non-invasive medical therapy consisting of an injectable viscous gel for the biomechanics of the spine and helps in alleviating what causes lower back pain patients, enabling patients with a treatment option for patients suffering from low back pain problems.
Contact Information
Website
www.ncbiomatrix.comCorporate Office
- Groene Loper 5
- 5612 AE Eindhoven
- Netherlands
Corporate Office
- Groene Loper 5
- 5612 AE Eindhoven
- Netherlands
NC Biomatrix Timeline
NC Biomatrix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 01-Jun-2024 | $426K | Completed | Pre-Clinical Trials | ||
| 11. Grant | 01-Jun-2023 | Completed | Pre-Clinical Trials | |||
| 10. Early Stage VC (Series A) | 16-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 05-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 8. Accelerator/Incubator | 01-May-2022 | Completed | Pre-Clinical Trials | |||
| 7. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 6. Early Stage VC | 12-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC | 01-Apr-2020 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 17-Feb-2020 | $220K | $220K | Completed | Startup | |
| 3. Seed Round | 05-Apr-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NC Biomatrix Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NC Biomatrix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NC Biomatrix Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Horizon Europe | Not-For-Profit Venture Capital | |||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| BraVenture | Accelerator/Incubator | |||
| dsm-firmenich Ventures | Corporate Venture Capital | Minority | ||
| Brabant Startup Fund | Venture Capital | Minority |
NC Biomatrix FAQs
-
When was NC Biomatrix founded?
NC Biomatrix was founded in 2019.
-
Where is NC Biomatrix headquartered?
NC Biomatrix is headquartered in Eindhoven, Netherlands.
-
What is the size of NC Biomatrix?
NC Biomatrix has 3 total employees.
-
What industry is NC Biomatrix in?
NC Biomatrix’s primary industry is Therapeutic Devices.
-
Is NC Biomatrix a private or public company?
NC Biomatrix is a Private company.
-
What is NC Biomatrix’s current revenue?
The current revenue for NC Biomatrix is .
-
How much funding has NC Biomatrix raised over time?
NC Biomatrix has raised $2.85M.
-
Who are NC Biomatrix’s investors?
Horizon Europe, European Innovation Council, BraVenture, dsm-firmenich Ventures, and Brabant Startup Fund are 5 of 9 investors who have invested in NC Biomatrix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
